A precision platform for the
biology of aging.
Thesis
Senescent cells accumulate in tissue and drive a measurable share of age-related disease. Molexir is building the computational and chemical tools to detect them, quantify their burden, and clear them — patient by patient.
/ Approach
Three problems, treated as one.
- 01 / Detect
Surface-proteome mapping
Machine-learning models trained on multi-omic atlases identify senescent-cell signatures across tissue types, resolving heterogeneity that bulk assays miss.
- 02 / Quantify
Longitudinal burden
A clinical-grade assay tracks senescent-cell load over time, giving clinicians a measurable endpoint for intervention rather than a chronological proxy.
- 03 / Clear
Matched senolytics
A small-molecule pipeline designed against the surface markers we identify — engineered for selectivity, sparing the healthy tissue around them.
- Stage
- Seed
- Focus
- Senolytics
- Modality
- Small molecule
- Status
- Preclinical
/ Stay informed
We publish quietly.
Periodic notes on our research, hiring, and clinical roadmap. For partnership or press, write directly to contact@molexir.com.